July 15th, 2021

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌…

July 12th, 2021

Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM –…

July 5th, 2021

This #SarcomaAwareness Month, please help raise awareness of the symptoms of bone sarcoma by liking and sharing our graphic below.

Symptoms of bone sarcoma / primary bone cancer can be very general and often appear similar to the symptoms of sports…

July 2nd, 2021

Listed below is a message sent by my late daughter Shayna two years ago (July 2, 2019) to promote Sarcoma Awareness Month.

Yesterday was the first day of Sarcoma Awareness Month. As someone that is currently fighting a sarcoma I can say that my…

June 27th, 2021

Published: Jun 21, 2021

SAN DIEGO, June 21, 2021 /PRNewswire/ — InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109…

June 19th, 2021

SUMMARY

This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in treating patients with conventional chondrosarcoma that cannot be removed by surgery (unresectable) and has spread to other places in…

June 3rd, 2021

Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health.

The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer Center (mskcc.org)

Transcript:

Barbra Rothschild:…

May 26th, 2021

Targeted Cancer Therapies

ON THIS PAGE

What are targeted cancer therapies?

How are targets for targeted cancer therapies identified?

How are targeted therapies developed?

What types of targeted therapies are available?

…

May 25th, 2021

Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript.

The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer…

May 16th, 2021

SAN DIEGO, Nov. 11, 2020 /PRNewswire/ –InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced updated interim results today from a Phase 1 clinical trial evaluating the efficacy and safety of…